Equities research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of Ampio Pharmaceuticals stock opened at $0.00 on Friday. The stock has a market capitalization of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.78. The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.01. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $1.99.
About Ampio Pharmaceuticals
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- Want to Profit on the Downtrend? Downtrends, Explained.
- How to Build the Ultimate Everything ETF Portfolio
- How to invest in marijuana stocks in 7 steps
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Stock Average Calculator
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.